At the epigenetic level, histone deacetylase (HDAC) inhibitors and DNA methylation modulators have demonstrated the ability to reverse transcriptional alterations in AD and ALS models [190,191]. Here, HDAC9 is linked to amyotrophic lateral sclerosis.